HomeCompareCYTHW vs DIVO

CYTHW vs DIVO: Dividend Comparison 2026

CYTHW yields 6250.00% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYTHW wins by $547038161900822.19M in total portfolio value
10 years
CYTHW
CYTHW
● Live price
6250.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$547038161900822.19M
Annual income
$530,345,833,482,145,900,000.00
Full CYTHW calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — CYTHW vs DIVO

📍 CYTHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYTHWDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYTHW + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYTHW pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYTHW
Annual income on $10K today (after 15% tax)
$531,250.00/yr
After 10yr DRIP, annual income (after tax)
$450,793,958,459,824,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, CYTHW beats the other by $450,793,958,459,824,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYTHW + DIVO for your $10,000?

CYTHW: 50%DIVO: 50%
100% DIVO50/50100% CYTHW
Portfolio after 10yr
$273519080950411.09M
Annual income
$265,172,916,741,072,950,000.00/yr
Blended yield
96.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CYTHW right now

CYTHW
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-46.3
Piotroski
2/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYTHW buys
0
DIVO buys
0
No recent congressional trades found for CYTHW or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYTHWDIVO
Forward yield6250.00%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$547038161900822.19M$30.7K
Annual income after 10y$530,345,833,482,145,900,000.00$981.68
Total dividends collected$545916230838674.88M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CYTHW vs DIVO ($10,000, DRIP)

YearCYTHW PortfolioCYTHW Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$635,700$625,000.00$11,349$649.42+$624.4KCYTHW
2$37,812,208$37,132,009.35$12,833$688.83+$37.80MCYTHW
3$2,104,624,511$2,064,165,448.17$14,459$727.90+$2104.61MCYTHW
4$109,626,980,731$107,375,032,504.06$16,238$766.49+$109626.96MCYTHW
5$5,344,419,538,811$5,227,118,669,428.94$18,179$804.47+$5344419.52MCYTHW
6$243,874,608,189,950$238,156,079,283,422.40$20,293$841.71+$243874608.17MCYTHW
7$10,417,442,627,867,752$10,156,496,797,104,504.00$22,591$878.14+$10417442627.85MCYTHW
8$416,612,895,336,954,560$405,466,231,725,136,060.00$25,087$913.65+$416612895336.93MCYTHW
9$15,600,306,933,342,350,000$15,154,531,135,331,807,000.00$27,791$948.18+$15600306933342.32MCYTHW
10$547,038,161,900,822,200,000$530,345,833,482,145,900,000.00$30,718$981.68+$547038161900822.19MCYTHW

CYTHW vs DIVO: Complete Analysis 2026

CYTHWStock

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Full CYTHW Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this CYTHW vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYTHW vs SCHDCYTHW vs JEPICYTHW vs OCYTHW vs KOCYTHW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.